MEI Pharma Inc (MEIP) — Capital Reinvestment Ratio
Latest as of December 2020:
0.01x
MEI Pharma Inc (MEIP) has a Capital Reinvestment Ratio of 0.01x as of December 2020, meaning it reinvests 0% of its operating cash flow ($4.05 Million) in capital expenditures ($56.00K). See cash generation quality of MEI Pharma Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$4.05 Million
USD
Capital Expenditures
$56.00K
USD
Data as of
Dec 2020
Most recent filing
MEI Pharma Inc Capital Reinvestment Ratio (2017–2020)
This chart tracks MEI Pharma Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for MEI Pharma Inc (2017–2020)
Year-by-year Capital Reinvestment Ratio for MEI Pharma Inc from 2017 to 2020. For live market cap and broader valuation context, see MEIP stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.03x | $34.26 Million | $894.00K | ▲ +78.4% |
| 2017 | 0.01x | $3.49 Million | $51.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow